Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
Nancy H Agee bought 10,645 shares of PGEN on 28 August at $4.65 per share, worth a total of $49K. They now own 202,841 PGEN shares, or a 6% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
